Charleston, SC -- (SBWIRE) -- 10/01/2013 -- Today’s Penny Stocks wants you, the investor, to have the ability to be informed in your trading decisions. Our website is designed to take you to the information you need to be at the top of your game in trading penny stocks. Today’s Penny Stocks issues news updates on the following stock: Sprint Corporation (NYSE:S), Array Biopharma Inc (NASDAQ:ARRY), Synta Pharmaceuticals Corp. (NASDAQ:SNTA), Amarin Corporation plc (ADR) (NASDAQ:AMRN).
Sprint Corporation (NYSE:S) ended its recent business day with the gain of 0.96% and closed at the price of $6.22 after opening at $6.09. The stock traded during its last trading session with the total volume of 11,255,301 shares, as compared to its average volume of 16.37 million shares. Sprint Corporation provides wireless and wireline communications services to consumers, businesses, and government users in the United States, Puerto Rico, and the U.S. Virgin Islands. It operates in two segments, Wireless and Wireline.
For How Long S will Fight for Profitability? Read This Trend Analysis report
Array Biopharma Inc (NASDAQ:ARRY) remained among the day advancers and traded with volume of 1,238,641 shares in the last session, as compared to average volume of 1.65 million shares. In comparison with 52 week range of $3.25 - $7.10, it faced lowest price of $6.01 during the last trading session whereas its day highest price was $6.27. The company’s total market capitalization is $727.85 million, along with 117.02 million shares outstanding. Array BioPharma Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule drugs to treat patients afflicted with cancer and inflammatory diseases primarily in North America, Europe, and the Asia Pacific.
For How Long ARRY’s Gloss will Attract Investors? Find out via this report
Synta Pharmaceuticals Corp. (NASDAQ:SNTA) showed 1,077,795 shares in volume during the last trading session, while the average trading volume remained 975,648.00 shares. The stock kicked off its trading session at $6.63 and closed at $6.31 after declining -5.54%. Synta Pharmaceuticals Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule drugs for treating severe medical conditions, including cancer and chronic inflammatory diseases.
Why Should Investors Buy SNTA After the Recent Fall? Just Go Here and Find Out
Amarin Corporation plc (ADR) (NASDAQ:AMRN) stock traded during its last trading session with the total traded volume of 2,550,911 shares versus its average volume of 4.75 million shares. The company opened its trade at the price of $6.44 and its closing price was $6.32 after losing -3.51% for the day. Amarin Corporation plc, a biopharmaceutical company, focuses on the development and commercialization therapeutic products for the treatment for cardiovascular diseases. Its product development program areas include lipid science and therapeutic benefits of polyunsaturated fatty acids.
Will AMRN Get Buyers Even After The Recent Rally? Find Out Here
About Today’s Penny Stocks:
Today’s Penny Stocks wants you, the investor, to have the ability to be informed in your trading decisions. Our website is designed to take you to the information you need to be at the top of your game in trading penny stocks. Today’s wants you to do your own due diligence on your investments please use our site to find the information you need on whichever investment you choose.
The disclaimer is to be read and fully understood before using our site, or joining our newsletter email list. Never invest into a stock discussed on this web site or the TodaysPennyStocks.com newsletter unless you can afford to lose your entire investment.
Please consult with a certified financial advisor before making any investment decisions.
TodaysPennyStocks.com is owned and operated by FlipVentures LLC. We are engaged in the business of advertising and promoting companies for monetary compensation. All content in our releases is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Read Full Disclaimer at: http://todayspennystocks.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)